| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |